Kinetics of hydrolysis of 1,4-benzodiazepine derivative by carboxylesterases in mice organism

Chemical modification of the physiologically active substances and creation of prodrugs is one of the ways for pharmacotherapy optimization. The aim of the work was determination of the kinetic parameters of nonspecific esterases that catalyze hydrolysis of new hypnotic drug Levana (1,4-benzodiazepi...

Full description

Bibliographic Details
Main Author: M. Ya. Golovenko, V. B. Larionov
Format: Article
Language:English
Published: National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry 2014-08-01
Series:The Ukrainian Biochemical Journal
Subjects:
Online Access:http://ukrbiochemjournal.org/wp-content/uploads/2015/06/Golovenko_4_14.pdf
_version_ 1797427829772648448
author M. Ya. Golovenko, V. B. Larionov
M. Ya. Golovenko, V. B. Larionov
author_facet M. Ya. Golovenko, V. B. Larionov
M. Ya. Golovenko, V. B. Larionov
author_sort M. Ya. Golovenko, V. B. Larionov
collection DOAJ
description Chemical modification of the physiologically active substances and creation of prodrugs is one of the ways for pharmacotherapy optimization. The aim of the work was determination of the kinetic parameters of nonspecific esterases that catalyze hydrolysis of new hypnotic drug Levana (1,4-benzodiazepine derivative). The experiments were carried out using the 14C-labelled Levana and its active metabolite – 3-hydrixyphenazepam. In vitro it was shown that Levana undergoes spontaneous hydrolysis even in buffer solution (pH 7.4), though in plasma and homogenates of brain and liver this process is more intensive (conventional Vmax was 6.9 ± 0.5, 19 ± 4 and 12 ± 1 mM/(h∙mg of protein, correspondingly). The samples mentioned differ by activity of tissue estera­ses being most active in the liver (conventional Km 0.45 ± 0.04 mM for the liver and 47 ± 11 mM for the brain). In plasma carboxylesterase activity (for Leva­na) is the lowest (conventional Km 129 ± 10 mM). In vivo it was shown that Levana more easily permeates brain-blood barrier (compared to 3-hydroxyphenaze­pam), that leads to higher concentrations (after hyd­rolysis) of its metabolite in brain tissue. Also it is quantitatively estimated as the increase of concentration (brain/blood) ratio ~1.4 times.
first_indexed 2024-03-09T08:50:25Z
format Article
id doaj.art-ef6c6937f36b4c8583ed01007fec8d71
institution Directory Open Access Journal
issn 2409-4943
2413-5003
language English
last_indexed 2024-03-09T08:50:25Z
publishDate 2014-08-01
publisher National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry
record_format Article
series The Ukrainian Biochemical Journal
spelling doaj.art-ef6c6937f36b4c8583ed01007fec8d712023-12-02T14:35:55ZengNational Academy of Sciences of Ukraine, Palladin Institute of BiochemistryThe Ukrainian Biochemical Journal2409-49432413-50032014-08-0186415015710.15407/ubj86.04.150Kinetics of hydrolysis of 1,4-benzodiazepine derivative by carboxylesterases in mice organismM. Ya. Golovenko, V. B. Larionov0M. Ya. Golovenko, V. B. Larionov1A. V. Bogatsky Physics-Chemical Institute, National Academy of Sciences of Ukraine, Odesa;A. V. Bogatsky Physics-Chemical Institute, National Academy of Sciences of Ukraine, Odesa;Chemical modification of the physiologically active substances and creation of prodrugs is one of the ways for pharmacotherapy optimization. The aim of the work was determination of the kinetic parameters of nonspecific esterases that catalyze hydrolysis of new hypnotic drug Levana (1,4-benzodiazepine derivative). The experiments were carried out using the 14C-labelled Levana and its active metabolite – 3-hydrixyphenazepam. In vitro it was shown that Levana undergoes spontaneous hydrolysis even in buffer solution (pH 7.4), though in plasma and homogenates of brain and liver this process is more intensive (conventional Vmax was 6.9 ± 0.5, 19 ± 4 and 12 ± 1 mM/(h∙mg of protein, correspondingly). The samples mentioned differ by activity of tissue estera­ses being most active in the liver (conventional Km 0.45 ± 0.04 mM for the liver and 47 ± 11 mM for the brain). In plasma carboxylesterase activity (for Leva­na) is the lowest (conventional Km 129 ± 10 mM). In vivo it was shown that Levana more easily permeates brain-blood barrier (compared to 3-hydroxyphenaze­pam), that leads to higher concentrations (after hyd­rolysis) of its metabolite in brain tissue. Also it is quantitatively estimated as the increase of concentration (brain/blood) ratio ~1.4 times.http://ukrbiochemjournal.org/wp-content/uploads/2015/06/Golovenko_4_14.pdf3-hydroxyphenaze­pambrain-blood barrierdrug "Levana"enzymatic hydrolysisprodrug
spellingShingle M. Ya. Golovenko, V. B. Larionov
M. Ya. Golovenko, V. B. Larionov
Kinetics of hydrolysis of 1,4-benzodiazepine derivative by carboxylesterases in mice organism
The Ukrainian Biochemical Journal
3-hydroxyphenaze­pam
brain-blood barrier
drug "Levana"
enzymatic hydrolysis
prodrug
title Kinetics of hydrolysis of 1,4-benzodiazepine derivative by carboxylesterases in mice organism
title_full Kinetics of hydrolysis of 1,4-benzodiazepine derivative by carboxylesterases in mice organism
title_fullStr Kinetics of hydrolysis of 1,4-benzodiazepine derivative by carboxylesterases in mice organism
title_full_unstemmed Kinetics of hydrolysis of 1,4-benzodiazepine derivative by carboxylesterases in mice organism
title_short Kinetics of hydrolysis of 1,4-benzodiazepine derivative by carboxylesterases in mice organism
title_sort kinetics of hydrolysis of 1 4 benzodiazepine derivative by carboxylesterases in mice organism
topic 3-hydroxyphenaze­pam
brain-blood barrier
drug "Levana"
enzymatic hydrolysis
prodrug
url http://ukrbiochemjournal.org/wp-content/uploads/2015/06/Golovenko_4_14.pdf
work_keys_str_mv AT myagolovenkovblarionov kineticsofhydrolysisof14benzodiazepinederivativebycarboxylesterasesinmiceorganism
AT myagolovenkovblarionov kineticsofhydrolysisof14benzodiazepinederivativebycarboxylesterasesinmiceorganism